Verona pharma to present at jefferies virtual healthcare conference

London and raleigh, n.c., may 25, 2021 (globe newswire) -- verona pharma plc (nasdaq: vrna) (“verona pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that david zaccardelli, chief executive officer and president, will present a company overview at the jefferies virtual healthcare conference on tuesday, june 1, 2021 at 9:00 am et.

VRNA Ratings Summary

VRNA Quant Ranking